Micro Text Module #2 with downloadable slides

Pushing the Boundaries of Unresectable or Metastatic HER2-Low Breast Cancer Treatment: New Insights and Innovations

Share

Program Content

Activities

  • HER2 Low Advanced BC: Module
    Pushing the Boundaries of Unresectable or Metastatic HER2-Low Breast Cancer Treatment: New Insights and Innovations
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 26, 2024

    Expires: January 25, 2025

  • HER2 Low Advanced BC: Slides
    Pushing the Boundaries of Unresectable or Metastatic HER2-Low Breast Cancer Treatment: New Insights and Innovations
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 26, 2024

Faculty

cover img faculity

Sara M. Tolaney, MD, MPH

Chief, Division of Breast Oncology
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.